Profund Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $417K | Sell |
8,187
-2,815
| -26% | -$143K | 0.02% | 529 |
|
|
2025
Q1 | $496K | Buy |
11,002
+1,820
| +20% | +$82K | 0.02% | 476 |
|
|
2024
Q4 | $380K | Sell |
9,182
-7,802
| -46% | -$323K | 0.01% | 655 |
|
|
2024
Q3 | $662K | Buy |
16,984
+3,976
| +31% | +$155K | 0.03% | 425 |
|
|
2024
Q2 | $445K | Sell |
13,008
-27,856
| -68% | -$952K | 0.02% | 540 |
|
|
2024
Q1 | $1.03M | Buy |
40,864
+19,694
| +93% | +$495K | 0.04% | 355 |
|
|
2023
Q4 | $625K | Sell |
21,170
-1,886
| -8% | -$55.7K | 0.03% | 447 |
|
|
2023
Q3 | $729K | Buy |
23,056
+1,940
| +9% | +$61.3K | 0.04% | 361 |
|
|
2023
Q2 | $546K | Buy |
21,116
+5,107
| +32% | +$132K | 0.03% | 488 |
|
|
2023
Q1 | $385K | Buy |
+16,009
| New | +$385K | 0.02% | 609 |
|